how is tirzepatide injected Shots Tirzepatide injection training
Description
Yiannakopoulou, E.C., 2014
Discard any unused solution after 30 days
A permanent five-day schedule produces continuously elevated drug levels that compound with every injection, pushing further above the tested range with each cycle until a new, higher steady state is reached
Orforglipron significantly reduced HbA1c to 2.1% in a phase II clinical trial assessing its use in T2DM, while dulaglutide achieved 1.1% and a placebo achieved 0.43% [106]
First, the GIP component may explain why tirzepatide produces comparable or even lower rates of nausea despite stronger weight loss
